Medtronic (MDT 0.27%), one of the largest medical-device players on the planet, reported its fourth-quarter earnings today, and investors were clearly pleased with the results. Shares were up 4.9% by the market close, and this stock is up more than 30% over the past 12 months. But which segments drove the company's business in Q4? How did Medtronic's results measure up against its medical-device peers, like Boston Scientific (BSX -0.19%) and St. Jude Medical (STJ)? Health-care analyst Max Macaluso discusses these topics in the following video.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.